Rentokil
191 hedge funds and large institutions have $1.95B invested in Rentokil in 2023 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 56 increasing their positions, 55 reducing their positions, and 15 closing their positions.
187% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 15
19% more capital invested
Capital invested by funds: $1.63B → $1.95B (+$318M)
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
14% more funds holding
Funds holding: 167 → 191 (+24)
2% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 55
0.02% more ownership
Funds ownership: 2.1% → 2.12% (+0.02%)
99% less call options, than puts
Call options by funds: $285K | Put options by funds: $31.3M
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$39.4M |
| 2 |
Morgan Stanley
New York
|
-$37.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$34M |
| 4 |
TSAM
Trinity Street Asset Management
London,
United Kingdom
|
-$12.8M |
| 5 |
D.E. Shaw & Co
New York
|
-$10.7M |
RTO Hedge Fund Activity: Q1 2023 in Review
191 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Rentokil (RTO) for Q1 2023, worth a combined $1.95B — up 19% from $1.63B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new RTO positions and 15 closed out — a net gain of 28 holders — while 56 added to existing stakes and 55 trimmed.
The largest buyer was Schroder Investment Management Group, opening a new position worth an estimated $76.9M. The largest seller was JP Morgan Chase, cutting an estimated $39.4M.
- 191 institutional investors held Rentokil (RTO) as of Q1 2023, up from 167 in Q4 2022.
- Funds reported $1.95B of Rentokil stock for Q1 2023, up 19% quarter-over-quarter.
- 43 funds opened new Rentokil positions in Q1 2023 and 15 closed out, a net change of +28 holders.
- The largest Rentokil buyer in Q1 2023 was Schroder Investment Management Group, an estimated $76.9M added.
- The largest Rentokil seller in Q1 2023 was JP Morgan Chase, an estimated $39.4M sold.
Based on aggregated 13F filings for Q1 2023.